Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAESTRO: Biomarkers for TIA Diagnosis
NCT02799511Completed
- Sponsor
- CHU Caen Normandie
- Start
- Mar 2015
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU Caen Normandie. Primary endpoint: Change in proteomic analysis from microparticles or plasma at 90 days. Started Mar 2015; status: completed.
Beyond the preview
Go deeper on NCT02799511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799511.